Align Technology Inc Stock Price, News & Analysis

Align Technology (NASDAQ:ALGN) has been announced as the title sponsor of Operation Smile's International Student Leadership Conference (ISLC) for the fifth consecutive year. The conference, in its 33rd year, will be held at the University of Maryland from July 21-27, 2025.

Align has committed over $1.6 million to student programs with Operation Smile, providing more than 130 scholarships since ISLC 2022. The scholarships cover travel costs and conference fees for students born with cleft conditions and those facing financial barriers across Operation Smile's network of 13,500 student volunteers from over 40 countries.

The partnership between Align Technology and Operation Smile spans more than a decade, supporting care for patients and working towards surgical excellence in 37 low- and middle-income countries.

Align Technology (NASDAQ: ALGN) has announced a strategic collaboration with Disney's upcoming movie sequel "Freakier Friday," set to release on August 8, 2025. The partnership features actress Julia Butters, a real-life Invisalign user, and includes product placement in the film alongside a comprehensive marketing campaign.

The multi-faceted collaboration encompasses co-branded content, social media campaigns, doctor's office activations, a Snapchat AR lens, and premiere events. The campaign aims to showcase how Invisalign clear aligners offer teens an effective and modern way to achieve confident smiles, while highlighting the system's near-invisibility and ease of use.

The marketing initiative leverages multiple channels including Disney+, Hulu, social media platforms, and orthodontist offices, reinforcing Align's commitment to teen confidence through smile transformation.

Align Technology (NASDAQ:ALGN) has announced the commercial availability of its innovative Invisalign System with mandibular advancement featuring occlusal blocks in India. This groundbreaking clear aligner product is specifically designed for Class II skeletal and dental correction in growing patients aged 10-16 years.

The system features integrated solid occlusal blocks that enable simultaneous mandibular advancement while aligning teeth, addressing approximately 30-45% of global malocclusions. Key benefits include efficient treatment through a single process, enhanced patient comfort with SmartTrack material, and predictable tooth movement using SmartForce features and SmartStage technology.

The product is currently available to Invisalign-trained doctors in Australia, New Zealand, Japan, Hong Kong, and India, with planned expansion to additional APAC markets later in 2025.

Align Technology (NASDAQ:ALGN) has announced the commercial launch of its Invisalign® Palatal Expander System in India following approval as a Class B medical device by the Central Drugs Standard Control Organization (CDSCO). This innovative system represents Align's first direct 3D printed orthodontic appliance.

The system offers a metal-free, removable alternative to traditional palatal expanders for treating skeletal and dental narrow maxilla. When combined with Invisalign First™ aligners, it provides doctors with a comprehensive early intervention treatment solution. The technology uses AI-driven orthodontic software and iTero™ intraoral digital scans to create customized devices that are changed daily, eliminating the need for manual screw adjustments.

This expansion into India follows successful launches in other Asia Pacific markets, including Australia, New Zealand, Hong Kong, Singapore, Vietnam, Japan, and Thailand, targeting the growing Phase 1 orthodontic treatment market, which represents 20% of orthodontic case starts annually.

Align Technology (NASDAQ: ALGN) has appointed Britt Vitalone, Executive Vice President and CFO of McKesson Corporation, to its Board of Directors and Audit Committee. Vitalone brings extensive healthcare industry financial expertise to Align's board, which has now expanded to 11 directors.

As McKesson's CFO, Vitalone oversees crucial functions including accounting, financial planning, treasury, investor relations, M&A, and tax. He also manages global procurement, corporate security, and McKesson Technology. Vitalone, who joined McKesson in 2006, will be included in Align's slate of director nominees for the 2026 Annual Meeting of Shareholders.

Align Technology (NASDAQ: ALGN), a global leader in digital orthodontics and restorative dentistry, has scheduled its second quarter 2025 financial results announcement for July 30, 2025, after market close at 4:00 p.m. ET.

The company will host a conference call at 4:30 p.m. ET to discuss the results, which will be accessible via webcast through the company's Investor Relations website. An archived version of the webcast will remain available for one month following the call.

Align Technology is known for its Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software. The company has served over 20.1 million patients through its network of 281.4 thousand doctor customers worldwide.

[]

Align Technology (NASDAQ:ALGN) hosted its 2025 Invisalign® Asia Pacific Summit in Bangkok, Thailand, attracting over 2,000 doctors and practice staff. The event celebrated reaching 20 million Invisalign smiles globally and 3 million smiles across Asia Pacific.

The three-day summit featured 60+ expert speakers and 50+ breakout sessions focusing on kids and teens, complex treatments, comprehensive dentistry, and practice growth. The Innovation Hub showcased developments including Invisalign First™, Invisalign® Palatal Expander System, and iTero Lumina™ Pro dental imaging system.

Additionally, the adjacent Align APAC University Forum at Chulalongkorn University gathered 300 delegates from 78 universities to discuss academic excellence and clinical training integration.

Align Technology (NASDAQ: ALGN) has launched integrated global marketing campaigns targeting kids and teens for its Invisalign clear aligner system. The initiative includes the 'Invisalign for Kids' consumer campaign educating parents about treatment benefits and the 'Growing Patients' professional campaign supporting doctors with product information. The campaigns highlight Align's extensive portfolio for growing patients, including the Invisalign Palatal Expander System, Invisalign First, and Invisalign System with mandibular advancement. This launch is part of Align's celebration of reaching 20 million Invisalign patients globally, with 5.8 million being kids and teens. The company emphasizes that children should be screened by orthodontists by age 7, offering Phase 1 treatment for ages 6-10 and Phase 2 treatment once permanent teeth are in place.

Align Technology (NASDAQ: ALGN) has awarded twelve research grants to universities globally through its fifteenth Annual Research Award Program, totaling $300,000 in funding. The grants support research across the Americas, Europe, and Asia Pacific regions, focusing on advancing orthodontic and dental research. The funded studies cover various topics related to Invisalign clear aligners, including adolescent treatment adherence, clinical consultation methods, attachment bonding precision, and comparative analyses with traditional orthodontic approaches. The research program received its highest number of applications since its inception 15 years ago. Applications underwent blind evaluation by an independent academic committee before final selection by Align Technology. The company aims to advance dental science and improve global dental care through these research initiatives.